165 related articles for article (PubMed ID: 12780783)
1. Mechanism of action of purine analogues in chronic lymphocytic leukaemia.
Pettitt AR
Br J Haematol; 2003 Jun; 121(5):692-702. PubMed ID: 12780783
[No Abstract] [Full Text] [Related]
2. Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines.
Wilson PK; Szabados E; Mulligan SP; Christopherson RI
Int J Biochem Cell Biol; 1998 Jul; 30(7):833-42. PubMed ID: 9722988
[TBL] [Abstract][Full Text] [Related]
3. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
Saven A; Piro LD
Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
[TBL] [Abstract][Full Text] [Related]
4. New purine analogues for the treatment of chronic B-cell malignancies.
Gribbin TE
Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
[TBL] [Abstract][Full Text] [Related]
5. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Van den Neste E; Cardoen S; Offner F; Bontemps F
Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
[TBL] [Abstract][Full Text] [Related]
6. Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs.
Starczewska E; Beyaert M; Michaux L; Vekemans MC; Saussoy P; Bol V; Arana Echarri A; Smal C; Van Den Neste E; Bontemps F
Oncotarget; 2016 Jun; 7(25):38367-38379. PubMed ID: 27223263
[TBL] [Abstract][Full Text] [Related]
7. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues.
Pettitt AR; Sherrington PD; Cawley JC
Cancer Res; 2000 Aug; 60(15):4187-93. PubMed ID: 10945628
[TBL] [Abstract][Full Text] [Related]
8. Purine analogs in leukemia.
Lamanna N; Weiss M
Adv Pharmacol; 2004; 51():107-25. PubMed ID: 15464907
[No Abstract] [Full Text] [Related]
9. Chemosensitivity in vitro to 2-chlorodeoxyadenosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in previously unexposed cases of chronic lymphocytic leukemia.
Koski T; Vilpo L; Vilpo J
Leuk Res; 1999 Mar; 23(3):277-9. PubMed ID: 10071081
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells.
Zinzani PL; Tosi P; Visani G; Martinelli G; Farabegoli P; Buzzi M; Ottaviani E; Salvucci M; Bendandi M; Zaccaria A
Am J Hematol; 1994 Dec; 47(4):301-6. PubMed ID: 7977303
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia.
Bosanquet AG; Bosanquet MI
Leukemia; 2000 Apr; 14(4):712-5. PubMed ID: 10764159
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia.
Podhorecka M; Halicka D; Klimek P; Kowal M; Chocholska S; Dmoszynska A
Ann Hematol; 2011 Feb; 90(2):173-83. PubMed ID: 20714724
[TBL] [Abstract][Full Text] [Related]
13. Potential immunological action of purine nucleoside analogues.
Dighiero G
Drugs; 1994; 47 Suppl 6():57-62. PubMed ID: 7525190
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells.
Podhorecka M; Halicka D; Klimek P; Kowal M; Chocholska S; Dmoszynska A
Ann Hematol; 2010 Nov; 89(11):1115-24. PubMed ID: 20499237
[TBL] [Abstract][Full Text] [Related]
15. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT
Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity.
Kohnke PL; Mactier S; Almazi JG; Crossett B; Christopherson RI
J Proteome Res; 2012 Sep; 11(9):4436-48. PubMed ID: 22839105
[TBL] [Abstract][Full Text] [Related]
17. Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin.
Wilson PK; Mulligan SP; Christopherson RI
Leuk Res; 2004 Jul; 28(7):725-31. PubMed ID: 15158094
[TBL] [Abstract][Full Text] [Related]
18. Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response.
de Viron E; Knoops L; Connerotte T; Smal C; Michaux L; Saussoy P; Vannuffel P; Beert E; Vekemans MC; Hermans C; Bontemps F; Van Den Neste E
Br J Haematol; 2009 Dec; 147(5):641-52. PubMed ID: 19764992
[TBL] [Abstract][Full Text] [Related]
19. More on purine analog-induced apoptosis in B cell chronic lymphocytic leukemia.
Morabito F; Filangeri M; Sculli G; Oliva B
Leukemia; 1998 Apr; 12(4):633-5. PubMed ID: 9557625
[No Abstract] [Full Text] [Related]
20. Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies.
Johnson SA; Thomas W
Hematol Oncol; 2000 Dec; 18(4):141-153. PubMed ID: 11135355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]